Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target.

Journal of Cancer Research and Clinical Oncology
Mitsutsune WashiroMasaru Miyazaki

Abstract

The lack of treatment options other than surgical resection results in unfavourable prognosis of advanced gallbladder carcinoma. The aim of this study was to identify cancer-specific cellular targets that would form the basis for some therapeutic approaches for this disease. Twelve advanced gallbladder carcinoma tissue samples and three samples of normal gallbladder epithelium were screened to identify differentially expressed genes by DNA microarray analysis. The results obtained were validated in an independent sample set by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR). Among the genes picked-up, one molecule, topoisomerase IIalpha (TOPO IIalpha), was further assessed immunohistochemically as a potential chemotherapeutic target, and the growth inhibitory effects of etoposide, doxorubicin and idarubicin, representative TOPO IIalpha inhibitors, on two different gallbladder carcinoma cell lines were compared with that of gemcitabine and 5-fulorouracil. Five upregulated genes were identified: four cell cycle-related genes (TOPO IIalpha, cyclin B2, CDC28 protein kinase regulatory subunit 2, ubiquitin-conjugating enzyme E2C) and a metabolism-related gene (gamma-glutamyl hydrolase). Immunohistochem...Continue Reading

References

Dec 1, 1995·Current Opinion in Cell Biology·G I EvanE Harrington
Apr 1, 1996·The British Journal of Surgery·M MiyazakiT Suwa
Dec 1, 1996·Current Opinion in Cell Biology·D J Lew, S Kornbluth
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·F M TownsleyJ V Ruderman
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S B SaxmanL H Einhorn
Jun 25, 1998·Molecular and Cellular Biology·E A Egan, M J Solomon
Aug 24, 2000·American Journal of Clinical Oncology·C W ChoiY H Kim
Apr 18, 2001·Journal of Clinical Pathology·L NakopoulouC Dimopoulos
Feb 28, 2002·The Journal of Biological Chemistry·Natalie O KarpinichJohn L Farber
Apr 17, 2002·Journal of Hepato-biliary-pancreatic Surgery·J H Donohue
Jun 18, 2002·The Lancet Oncology·Udo KellnerPierre Rudolph
Mar 8, 2003·The Lancet Oncology·Sanjeev MisraIndra D Sharma
Aug 14, 2003·British Journal of Cancer·G MacGroganJ M Coindre
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer J KnoxMalcolm J Moore
May 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·C-C ChiuK Fang
Dec 13, 2005·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Brian H DingleUNKNOWN Cancer Care Ontario's Program in Evidence-Based Care's Gastrointestinal Cancer Disease Site Group
Mar 21, 2006·Journal of Cellular Physiology·Natalie O KarpinichJohn L Farber
Jun 6, 2006·International Journal of Radiation Oncology, Biology, Physics·John K O'ConnorDavid K Gaffney

❮ Previous
Next ❯

Citations

Feb 19, 2009·Nucleic Acids Research·Michal StrosSárka Pospísilová
Nov 1, 2012·North American Journal of Medical Sciences·Ake Andrén-Sandberg
Jul 19, 2012·Digestive Diseases and Sciences·Wei WangHui-Zhen Zhang
Aug 31, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Kshitij SrivastavaBalraj Mittal
Jan 24, 2019·Molecular Oncology·Tao LiuMuxiang Zhou
May 15, 2009·Histopathology·Giancarlo TronconeAlfredo Fusco
Jun 15, 2010·Cancer Cytopathology·Eliana GuerrieroGiancarlo Troncone
May 16, 2019·Database : the Journal of Biological Databases and Curation·Ying WangXiaoyan Zhang
Dec 30, 2017·Molecular and Clinical Oncology·Asaf ShveroLea Rath-Wolfson
Jun 28, 2017·World Journal of Gastroenterology : WJG·Aarti SharmaAshok Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis